Background and methods. Clinical and microbiological features of maternal sepsis in the peripartum period (7 days before to 7 days after delivery) were analyzed to determine possible risk factors, optimal treatment and outcome. In 43 483 deliveries during 1990-98, laboratory-confirmed bacteremia was found in 41 (5.1%) out of 798 clinically suspected septic infections. Results. Preterm deliveries were associated with a crude 2.7-fold risk for peripartum sepsis as compared to term deliveries. Antepartum sepsis was associated with a crude 2.6-fold risk for cesarean section, while postpartum sepsis was 3.2 times more likely to occur after cesarean section than after vaginal delivery. A combination of cefuroxime and metronidazole was used in 80% (33/41) of all treatments. All mothers recovered well, and only one suffered from septic shock.
Maternal sepsis is a major clinical problem, causing up to 8% of maternal deaths and 15% of admissions to intensive care units (1, 2) . Furthermore, severe maternal infections are associated with abnormal neurological development such as cerebral palsy in their children (3, 4) . The incidence of septic shock, the most severe form of sepsis, appears to be low, at 1/7654-1/8338 deliveries (5) . So far, only limited data are available on the clinical outcome and causative microbes in peripartum sepsis (5, 6) . The aim of this study was to evaluate maternal outcome and the clinical, microbiological and laboratory findings in peripartum sepsis.
Materials and methods
This retrospective study was carried out at the Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland. The hospital serves both as a primary delivery unit for the Helsinki metropolitan area (population 1.1 million) and as the only tertiary referral center for the most complicated pregnancies.
Abbreviations:
CRP: C-reactive protein; BLC: blood leukocyte count; BE: base excess; BMI: body mass index; PROM: preterm rupture of the membranes.
Since 1989, diagnoses and laboratory test reports of all parturients have been stored in the hospital's electronic database. We searched delivery data from May 1990 to October 1998 for blood culture reports and for ICD-9 and ICD-10 coded diagnoses of all obstetric infections. All blood culture results were retrieved and the obstetric records were perused for those with bacterial growth. All records of subjects with ICD-9 or ICD-10 diagnoses of infection were also reviewed.
Throughout the study period, the routine clinical practice was to take a venous blood sample for bacterial culture within 24 h after the axillary temperature rose to !38 C and/or when there were other clinical indications to suggest a systemic infection, for example elevated C-reactive protein (CRP) levels or leukocytosis. Antimicrobial treatments were usually started immediately after blood samples for bacterial culture had been taken, and thus before the results of these cultures were available. During the study period, no prophylactic antibiotic treatments were administered prior to cesarean section or after identification of vaginal colonization by Group B streptococci. However, antibiotic prophylaxis with intravenous cefuroxime (1.5 g three times daily) was administered for women with preterm rupture of the membranes (PROM) starting from the year 1993.
Duplicate sterile venous blood samples for blood culture were taken at 30-min intervals into both aerobic and anaerobic bottles. The samples were sent to the clinical microbiology laboratory (HUCH Laboratory Diagnostics, Department of Bacteriology, Helsinki University Central Hospital) for isolation and identification of bacteria and antimicrobial susceptibility testing according to standard methods (7, 8) . The identification of the Actinomyces neuii strain was confirmed by Dr H. Jousimies-Somer, Anaerobe Reference Laboratory, National Public Health Institute, Helsinki, Finland.
During 1990-93, blood cultures were carried out with a Bactec blood culture system (NR-660, Becton Dickinson Instruments, Sparks, MD, USA), and during 1994-98 with a BacT/ Alert blood culture system (Organon Teknika, Durham, NC, USA). The preliminary blood culture results were usually ready within 1 day and the antimicrobial susceptibility test and identification results within 2 to 3 days after sampling.
Preterm delivery was defined as delivery before 37 gestational weeks. Peripartum sepsis was defined as bacterial growth in culture of blood taken 7 days before to 7 days after delivery. The mother's daily follow-up included clinical evaluation, fever measurement, assay of CRP (mg/L) and blood leukocyte count (BLC, Â 10 6 /L). The data are presented as mean AE standard deviation (SD). Relative risk (RR) and its 95% confidence interval (CI) were calculated for dichotomous parameters (9) .
Results
During the study period, there were 43 483 deliveries, of which 4569 (11%) were preterm, and 9904 (23%) were delivered by cesarean section. Venous blood samples for bacterial culture were taken from 798 (1.8%) parturients. Of these, 41 (5.1%) had bacterial growth in their blood. An additional eight positive findings were excluded from the study due to strong suspicion of contamination (three Staphylococcus epidermidis, two Micrococcus species, one Bacillus species, and two Propionibacterium species).
The incidence of peripartum sepsis in this study was 1/1060 deliveries (95% CI 1/781-1/ 1479) ( Table I) . Compared with other parturients, these women were more often primiparous and obese, their delivery was more often preterm, and they were more often delivered by cesarean section (Table I) . Perinatal mortality rate and proportion of newborns with Apgar scores less than 7 at 1 min after birth were also significantly different from the reference population (Table I ).
In Fig. 1 , the time and type of delivery are plotted against days from delivery to blood sampling. Among the 41 cases there were 10 (24%) preterm deliveries and seven (17%) cases of preterm rupture of the membranes. Preterm delivery was associated with a 2.7-fold risk for peripartum sepsis as compared to term delivery (10/4569 vs. 31/38 914; crude RR 2.7; 95% CI 1.3-5.6).
In samples taken during the antepartum period, the rate of bacteremia was 4.3 times higher (10/56) than in those taken postpartum (31/742; crude RR 4.3; 95% CI 2.2-8.3). Ten infections (24%, 10/41) were identified in the antepartum period, nine of them (90%) less than 12 h before delivery. Antepartum sepsis was associated with a 2.6-fold risk for cesarean delivery (6/9904 vs. 4/33 579; crude RR 2.6; 95% CI 1.6-4.4). All six cesarean sections after antepartum bacteremia were nonelective.
In 65% (20/31), postpartum sepsis occurred more than 24 h after delivery. At this time, sepsis was 6.3 times more common in women delivered by cesarean section as compared with those delivered vaginally (13/9896 vs. 7/33 566; RR 6.3; 95% CI 2.5-15.8). By contrast, within 24 h after delivery, no significant difference was observed in the rate of postpartum sepsis between cesarean section (2/9898) or vaginal delivery (9/33 575; crude RR 0.75, 95% CI 0.16-3.5). Thus the overall relative risk of sepsis after cesarean delivery was 3.2 (15/9898 vs. 16/33 575; crude RR 3.2; 95% CI 1.6-6.4) as compared to vaginal delivery. Of all the 15 cases of sepsis after cesarean section, seven (47%) occurred after elective and eight (53%) after emergency operations.
At the time of blood sampling, the patients' mean temperature was 39.2 AE 0.6 C (range 37.6-40.6 C) and mean CRP values were 93.5 AE 64 mg/L (range 0-235 mg/L) (Fig. 2) . Normal temperature levels were attained within 2.5 days after blood culture, CRP levels peaked at 1 day after blood culture (149 AE 55 mg/L, range 62-287 mg/L) and declined thereafter, lagging 1-3 days behind the temperature slope (Fig. 2) . In three cases (7.3%), fever did not rise above 38 C (range 37.6-37.8 C); these mothers had had an elevated BLC of (22.5 AE 0. (Table II) . Of the total number of bacterial strains, 88% (37/42) were aerobic and 12% (5/42) were anaerobic. The most frequent pathogens were betahemolytic streptococci, Staphylococcus aureus and Escherichia coli, which, taken together, were found in 68% (28/41) of cultures. After vaginal delivery, betahemolytic streptococci were the most commonly identified microbes (50%, 9/18). On the other hand, bacteremia after cesarean section was associated with growth of S. aureus or E. coli in the blood [26% (4/19) and 16% (3/19), respectively]. Furthermore, all five anaerobic infections were associated with cesarean delivery. One of these anaerobic strains was Actinomyces neuii. To our knowledge, this is the first report of peripartum sepsis associated with this pathogen (10) . Multibacterial growth in blood cultures was identified in only one case, which led to septic shock (see below). A simultaneous urinary tract infection was present in six (15%) of the 41 patients, three of these cases were caused by Enterococcus faecalis, two by E. coli and one by Staphylococcus species. Only one of these six patients harbored the same microbial species (E. coli) both in blood and urine.
All S. aureus strains were susceptible to oxacillin and to first-or second-generation cephalosporins. All E. coli strains were susceptible to second-generation cephalosporins. Among anaerobic bacteria, metronidazole resistance was found only in the intrinsically metronidazole-resistant but cefuroxime-susceptible A. neuii (10). Resistance to first-or second-generation cephalosporin was seen in only one (3.0%, Morganella morganii) of 33 bacterial strains tested.
Antimicrobial treatment was administered intravenously to 39 (95%) of 41 patients for a median duration of 5 days (range 1.0-13.5 days).
A combination of cefuroxime and metronidazole was used in 80% (33/41). Other intravenous antimicrobial treatment regimens were: cefuroxime, ceftazidime plus metronidazole, G-penicillin, erythromycin and gentamicin. Two (5%) of the 41 patients were treated solely with peroral antimicrobials (penicillin or cephalexin).
The primary antimicrobial regimen was changed in 13 (27%) of the 41 patients. In five, the switch was prompted by the results of blood culture and drug resistance assessment. The microbes involved in these six cases were Listeria monocytogenes, Enterococcus faecium and E. coli, Pseudomonas aeruginosa, M. morganii and Peptostreptococcus species. In the remaining eight patients the change in antimicrobial treatment was based on clinical indications, as the pathogens involved (four S. aureus, one Streptococcus pyogenes, one Streptococcus agalactiae, one Streptococcus viridans species and one E. coli) were found to be susceptible to antimicrobial agents used as primary treatment.
One patient with a positive blood culture for E. faecium and E. coli after vaginal delivery developed septic shock with disseminated intravascular coagulation. Her labor had been induced due to intrauterine fetal death. She received a combination of vancomycin, netilmicin and metronidazole intravenously for 13 days at the intensive care unit. She was also treated with vasopressors and received blood transfusions. She recovered well and was discharged 15 days after delivery.
Two (4.8%, 2/42) intrauterine fetal deaths occurred. In these cases, the mothers' infections were due to L. monocytogenes and, as mentioned earlier, E. coli and E. faecium. The fetuses were delivered preterm by the vaginal route at 26 and 23 gestational weeks, respectively.
Discussion
The incidence of peripartum sepsis was 0.1% in this study. Sepsis was associated with preterm delivery and cesarean section. Mothers with peripartum sepsis were also more often primiparous and obese as compared to the overall hospital population.
In previous reports the incidence of obstetric bacteremia or severe sepsis has ranged from 0.4 to 0.75% (11, 12) . Moreover, as compared to previously reported incidences of septic shock (1/7654-1/8338 deliveries) (13) , in the present study only one out of 43 483 mothers developed septic shock. Some of these differences may be because we studied the limited period between 1 week before and 1 week after delivery. Furthermore, the lower incidences may be partly Table II . Identified bacterial strains and their occurrence in blood cultures from 41 women with peripartum bacteremia. In one subject, two bacterial strains were isolated concomitantly
Aerobic bacteria
explained by differences in our background population, early diagnosis and promptly initiated antimicrobial treatment, which may have prevented the development of the most severe septic infections. The incidence of peripartum sepsis was three times higher in preterm than in term deliveries. Intra-amnionitic infection is a significant predisposing factor as regards maternal sepsis and may present as a chronic infection months after the initial microbial invasion (14) . Moreover, dysfunctional intrinsic defense mechanisms in preterm labor (15) can predispose the mother to sepsis. Thus our results indicate a need for clinical alertness for the possibility of developing sepsis when preterm labor is associated with clinical amnionitis.
We found that postpartum sepsis was three times more common after a cesarean section than after vaginal delivery, and this association was most apparent after 24 h from delivery. Our finding suggests that an underlying infectious process, for example low-grade chorioamnionitis, predisposes to dysfunctional labor requiring cesarean section. Probably this subclinical infection is then aggravated by tissue trauma associated with cesarean section (16) . Our findings support the importance of antimicrobial prophylaxis in all types of cesarean sections (17) . Furthermore, cesarean section was recently reported to quadruple the risk of maternal morbidity (18) . An antepartum diagnosis of maternal sepsis was associated with a 2.6-fold risk for cesarean section. This finding suggests that infection may be related to dysfunctional uterine contractions predisposing the fetus to asphyxia.
In contrast to well-established data on polymicrobial growth in amnionitis (5, 19) , we observed only one but nevertheless a serious polymicrobial septicemia. In the light of this information, it seems that usually only one type of bacterium gains access to the circulation and causes systemic infection. However, the microbe found in blood culture represents only the tip of an iceberg of pathogens at the original site of infection (5) . In fact it has been hypothesized that having invaded the myometrium the most virulent pathogen may spread into the systemic circulation through uterine contractions (6) . Even though the majority of bacteria cultured from blood samples were aerobic strains, anaerobic bacteria can have an important role in the initial infection. Thus, antimicrobial agents effective against anaerobes, such as metronidazole, may still be needed in treatment of maternal genital tract infections.
The rapid and good clinical response to intravenous antimicrobials in our study suggests that the therapy was appropriate and started early enough even if the result of the blood culture was not yet known. Treatment with a combination of cefuroxime and metronidazole was effective in 80% of cases. The most frequent pathogens associated with infection after vaginal delivery were group A and group B streptococci, while E. coli and S. aureus infections were associated with infection after cesarean section. All of them were tested susceptible to first-or second-generation cephalosporins. Nevertheless, whenever possible, a narrower spectrum second-line antimicrobial treatment should be selected on the basis of microbiological data to help to reduce microbial drug resistance (20, 21) .
In addition to second-generation cephalosporins, other treatment options are widely used elsewhere (13, 22, 23) . These include use of aminopenicillins (e.g. ampicillin) with aminoglycosides (e.g. netilmicin, gentamicin). The former are effective against L. monocytogenes and some enterococci, but do not withstand b-lactamase of, for example, staphylococci, which were frequent (17%) pathogens in our study. The fact that only one listerial and one enterococcal infection were found in our study suggests that use of ampicillin is not of primary importance in our pregnant population. Aminoglycosides have many adverse effects, such as oto-and nephrotoxicity, and a narrow therapeutic window requiring frequent drug serum level monitoring. Nevertheless, aminoglycosides and aminopenicillins serve as valuable second-line treatment options for the most complicated infections. The microbiological profile may change from place to place and from time to time, so each center caring for patients with complicated obstetric infections should periodically review the adequacy of its treatment policy.
Considering the rarity of peripartum sepsis and the multitude of bacteria involved, it is unlikely that randomized controlled trials of adequate power will be carried out in the near future. Therefore, treatment options must be based mainly on empiric observations. Taken prior to antimicrobial therapy, blood cultures for bacteriological typing and drug resistance measurements help to verify that the treatment chosen is optimal and provide a useful basis for changing the regimen when needed.
